03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Ketoftil UD² : | |
Type | Medicine Non Marketed |
Originator | G |
Agent | New Larys Pharm |
Distributor | New Larys Pharm |
Laboratory | Farmigea |
Responsible Party | Polifarma SpA |
Origin | Italy |
Manufacturer | Farmigea SPA |
Manufacturing Type | G |
Origin | Italy |
ATC | S01GX08 |
Ketoftil UD² :
Ketoftil UD² :
Ketoftil UD² :
Ketoftil UD² :
Ketoftil UD² :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Allergic reaction | Not known |
Asthma aggravated | Not known |
Conjunctival haemorrhage | Uncommon |
Conjunctivitis | Uncommon |
Dermatitis contact | Not known |
Dry eye | Uncommon |
Dry mouth (Xerostomia) | Uncommon |
Eczema | Uncommon |
Eczema exacerbated | Not known |
Eye irritation | Common |
Eye pain | Common |
Eye swelling | Not known |
Eyelid disorder | Uncommon |
Eyelid oedema | Not known |
Eyelid pruritus | Not known |
Face oedema | Not known |
Headache | Uncommon |
Hypersensitivity | Uncommon |
Hypersensitivity reactions | Not known |
Photophobia | Uncommon |
Punctate epithelial erosion | Common |
Punctate keratitis | Common |
Skin rash | Uncommon |
Somnolence | Uncommon |
Swelling face | Not known |
Systemic allergic reaction | Not known |
Urticaria | Uncommon |
Vision blurred | Uncommon |
Ketoftil UD² :
NB : Products With Same Indication |
Different Units By MoH Code
Ketoftil UD² MoH 10911 :
Form | Eye drops, solution in single-dose container |
Packaging | Single-dose containers |
Package Size | 25x0.5ml |
Strength | 0.05% |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 142420/1 |
Submission date | 2020 |
Registration Year | 06/09/2022 |
Archived Date | 03/05/2023 |
Price Comparison
● Country: | Italy |
● Package Size: | 25x0.5ml |
● Pricing Date: | 14/10/2019 |
You have to register to view this info
Drop File